Betel nut chewing history is an independent prognosticator for smoking patients with locally advanced stage IV head and neck squamous cell carcinoma receiving induction chemotherapy with docetaxel, cisplatin, and fluorouracil

被引：0
|
作者：
Yan-Ye Su
Chih-Yen Chien
Sheng-Dean Luo
Tai-Lin Huang
Wei-Che Lin
Fu-Min Fang
Tai-Jan Chiu
Yen-Hao Chen
Chi-Chih Lai
Cheng-Ming Hsu
Shau-Hsuan Li
机构：
[1] Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine,Department of Otolaryngology
[2] Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine,Department of Hematology
[3] Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine,Oncology
[4] Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine,Department of Diagnostic Radiology
[5] Kaohsiung Chang Gung Memorial Hospital,Department of Radiation Oncology
来源：
World Journal of Surgical Oncology | / 14卷
关键词：
Head and neck cancer; Squamous cell carcinoma; Betel nut; Smoking; Induction chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] nab-Paclitaxel-based induction chemotherapy with or without cetuximab for locally advanced head and neck squamous cell carcinoma
    Adkins, Douglas
    Ley, Jessica
    Oppelt, Peter
    Wildes, Tanya M.
    Gay, Hiram A.
    Daly, Mackenzie
    Rich, Jason
    Paniello, Randal C.
    Jackson, Ryan
    Pipkorn, Patrik
    Nussenbaum, Brian
    Trinkaus, Kathryn
    Thorstad, Wade
    ORAL ONCOLOGY, 2017, 72 : 26 - 31
  • [42] Efficacy and feasibility of induction chemotherapy with paclitaxel, carboplatin and cetuximab for locally advanced unresectable head and neck cancer patients ineligible for combination treatment with docetaxel, cisplatin, and 5-fluorouracil
    Shirasu, Hiromichi
    Yokota, Tomoya
    Kawakami, Takeshi
    Hamauchi, Satoshi
    Onozawa, Yusuke
    Ogawa, Hirofumi
    Onoe, Tsuyoshi
    Mori, Keita
    Onitsuka, Tetsuro
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (11) : 1914 - 1920
  • [43] Weekly paclitaxel, carboplatin, cetuximab, and cetuximab, docetaxel, cisplatin, and fluorouracil, followed by local therapy in previously untreated, locally advanced head and neck squamous cell carcinoma
    Haddad, R. I.
    Massarelli, E.
    Lee, J. J.
    Lin, H. Y.
    Hutcheson, K.
    Lewis, J.
    Garden, A. S.
    Blumenschein, G. R.
    William, W. N.
    Pharaon, R. R.
    Tishler, R. B.
    Glisson, B. S.
    Pickering, C.
    Gold, K. A.
    Johnson, F. M.
    Rabinowits, G.
    Ginsberg, L. E.
    Williams, M. D.
    Myers, J.
    Kies, M. S.
    Papadimitrakopoulou, V.
    ANNALS OF ONCOLOGY, 2019, 30 (03) : 471 - 477
  • [44] USEFULNESS OF INTERIM FDG-PET AFTER INDUCTION CHEMOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK RECEIVING SEQUENTIAL INDUCTION CHEMOTHERAPY FOLLOWED BY CONCURRENT CHEMORADIOTHERAPY
    Yoon, Dok Hyun
    Cho, Yoojin
    Kim, Sang Yoon
    Nam, Soon Yuhl
    Choi, Seung-Ho
    Roh, Jong-Lyel
    Lee, Sang-wook
    Song, Si Yeol
    Lee, Jeong Hyun
    Kim, Jae Seung
    Cho, Kyung-Ja
    Kim, Sung-Bae
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (01): : 118 - 125
  • [45] Docetaxel, cisplatin and 5-FU compared with docetaxel, cisplatin and cetuximab as induction chemotherapy in advanced squamous cell carcinoma of the head and neck: Results of a randomised phase II AGMT trial
    Keil, Felix
    Hartl, Maximilian
    Altorjai, Gabriela
    Berghold, Andrea
    Riedl, Regina
    Pecherstorfer, Martin
    Mayrbaeurl, Beate
    De Vries, Alexander
    Schuster, Judith
    Hackl, Jutta
    Fuereder, Thorsten
    Melchardt, Thomas
    Burian, Martin
    Greil, Richard
    EUROPEAN JOURNAL OF CANCER, 2021, 151 : 201 - 210
  • [46] Multicenter phase II study of weekly docetaxel, cisplatin, and S-1 (TPS) induction chemotherapy for locally advanced squamous cell cancer of the head and neck
    Bae, Woo Kyun
    Hwang, Jun Eul
    Shim, Hyun Jeong
    Cho, Sang Hee
    Lee, Ki Hyeong
    Han, Hye Suk
    Song, Eun-Kee
    Yun, Hwan Jung
    Cho, In Sung
    Lee, Joon Kyoo
    Lim, Sang-Chul
    Chung, Woong-Ki
    Chung, Ik-Joo
    BMC CANCER, 2013, 13
  • [47] Tumor Volume Reduction Rate to Induction Chemotherapy is a Prognostic Factor for Locally Advanced Head and Neck Squamous Cell Carcinoma: A Retrospective Cohort Study
    Lin, Ting-Chun
    Huang, Chi-Hsien
    Lien, Ming-Yu
    Cheng, Fu-Ming
    Li, Kai-Chiun
    Lin, Chih-Yuan
    Lin, Ying-Chun
    Liang, Ji-An
    Wang, Ti-Hao
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2022, 21
  • [48] Phase I/II trial of outpatient docetaxel, cisplatin, 5-fluorouracil, leucovorin (opTPFL) as induction for squamous cell carcinoma of the head and neck (SCCHN)
    Colevas, AD
    Norris, CM
    Tishler, RB
    Lamb, CC
    Fried, MP
    Goguen, LA
    Gopal, HV
    Costello, R
    Read, R
    Adak, S
    Posner, MR
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2002, 25 (02): : 153 - 159
  • [49] Multicenter phase II study of weekly docetaxel, cisplatin, and S-1 (TPS) induction chemotherapy for locally advanced squamous cell cancer of the head and neck
    Woo Kyun Bae
    Jun Eul Hwang
    Hyun Jeong Shim
    Sang Hee Cho
    Ki Hyeong Lee
    Hye Suk Han
    Eun-Kee Song
    Hwan Jung Yun
    In Sung Cho
    Joon Kyoo Lee
    Sang-Chul Lim
    Woong-Ki Chung
    Ik-Joo Chung
    BMC Cancer, 13
  • [50] Comparative Evaluation of Surgical Operability with and without Induction Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma
    Haraprathap Yelishetty
    Jitendra Singh Yadav
    Chandni Sethi
    Rachna Chaurasia
    Mayank Singh
    Sachin Mahur
    Shalini Tripathi
    Bomkar Bam
    Shraddha Gupta
    Indian Journal of Otolaryngology and Head & Neck Surgery, 2024, 76 : 626 - 632
12345